🔎 Trials Near Me

Utama › Mieloma Pelbagai › Arkansas

Kajian klinikal Mieloma Pelbagai di Arkansas

9 kajian untuk Mieloma Pelbagai sedang mencari peserta di lokasi di Arkansas.

Bandar di Arkansas

Teks kajian rasmi (Bahasa Inggeris)

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

  • Highlands Oncology Group, Springdale
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07518186

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

  • UAMS, Little Rock
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07258511

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

  • University of Arkansas for Medical Sciences, Little Rock
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT04634552

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

  • University of Arkansas for Medical Sciences, Little Rock
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT06297226

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

  • Mercy Hospital Fort Smith, Fort Smith
  • CARTI Cancer Center, Little Rock
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT04566328

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

  • Highlands Oncology Group - Springdale /ID# 267742, Springdale
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT05650632

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

  • Mercy Hospital Fort Smith, Fort Smith
  • CARTI Cancer Center, Little Rock
  • University of Arkansas for Medical Sciences, Little Rock
Mengambil pesertaFasa 3
Semua umur · Semua jantina · Dikemas kini 10 Jun 2026 · NCT05561387

Limited-duration Teclistamab

  • University of Arkansas for Medical Sciences, Little Rock
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2025 · NCT05932680

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.